These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 25927944)
1. Traditional clinical risk factors predict clopidogrel hypo-responsiveness in unselected patients undergoing non-emergent percutaneous coronary intervention. Ratcovich H; Holmvang L; Johansson PI; Parup Dridi N Platelets; 2016; 27(1):51-8. PubMed ID: 25927944 [TBL] [Abstract][Full Text] [Related]
2. Impact of gene polymorphisms, platelet reactivity, and the SYNTAX score on 1-year clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: the GEPRESS study. Palmerini T; Calabrò P; Piscione F; De Servi S; Cattaneo M; Maffeo D; Toso A; Bartorelli A; Palmieri C; De Carlo M; Capodanno D; Barozzi C; Tomasi L; Della Riva D; Mariani A; Taglieri N; Reggiani LB; Bianchi R; De Rosa R; Mariani M; Podda G; Généreux P; Stone GW; Angiolillo DJ JACC Cardiovasc Interv; 2014 Oct; 7(10):1117-27. PubMed ID: 25240538 [TBL] [Abstract][Full Text] [Related]
3. Platelet and leukocyte ROS production and lipoperoxidation are associated with high platelet reactivity in Non-ST elevation myocardial infarction (NSTEMI) patients on dual antiplatelet treatment. Becatti M; Fiorillo C; Gori AM; Marcucci R; Paniccia R; Giusti B; Violi F; Pignatelli P; Gensini GF; Abbate R Atherosclerosis; 2013 Dec; 231(2):392-400. PubMed ID: 24267257 [TBL] [Abstract][Full Text] [Related]
4. Dual non-responsiveness to antiplatelet treatment is a stronger predictor of cardiac adverse events than isolated non-responsiveness to clopidogrel or aspirin. Siller-Matula JM; Delle-Karth G; Christ G; Neunteufl T; Maurer G; Huber K; Tolios A; Drucker C; Jilma B Int J Cardiol; 2013 Jul; 167(2):430-5. PubMed ID: 22305813 [TBL] [Abstract][Full Text] [Related]
5. Point-of-care testing of clopidogrel-mediated platelet inhibition and risk for cardiovascular events after coronary angiography with or without percutaneous coronary intervention. Holm M; Dalén M; Tornvall P; van der Linden J Blood Coagul Fibrinolysis; 2014 Sep; 25(6):577-84. PubMed ID: 24614428 [TBL] [Abstract][Full Text] [Related]
6. High post-clopidogrel platelet reactivity assessed by a point-of-care assay predicts long-term clinical outcomes in patients with ST-segment elevation myocardial infarction who underwent primary coronary stenting. Jin HY; Yang TH; Kim DI; Chung SR; Seo JS; Jang JS; Kim DK; Kim DK; Kim KH; Seol SH; Nam CW; Hur SH; Kim W; Park JS; Kim YJ; Kim DS Int J Cardiol; 2013 Sep; 167(5):1877-81. PubMed ID: 22682702 [TBL] [Abstract][Full Text] [Related]
7. High on clopidogrel treatment platelet reactivity is frequent in acute and rare in elective stenting and can be functionally overcome by switch of therapy. Leé S; Vargová K; Hizoh I; Horváth Z; Gulácsi-Bárdos P; Sztupinszki Z; Apró A; Kovács A; Préda I; Tóth-Zsámboki E; Kiss RG Thromb Res; 2014 Feb; 133(2):257-64. PubMed ID: 24359966 [TBL] [Abstract][Full Text] [Related]
8. The STIB score: a simple clinical test to predict clopidogrel resistance. Legrand D; Barbato E; Chenu P; Magne J; Vrolix M; Wijns W; Legrand V; Acta Cardiol; 2015 Oct; 70(5):516-21. PubMed ID: 26567810 [TBL] [Abstract][Full Text] [Related]
9. Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial. Legrand V; Cuisset T; Chenu P; Vrolix M; Martinez C; Dens J; Gach O; Boland J; Claeys MJ; Magne J; Barbato E; Wijns W EuroIntervention; 2014 Jun; 10(2):204-11. PubMed ID: 24952058 [TBL] [Abstract][Full Text] [Related]
10. Transferring from clopidogrel loading dose to prasugrel loading dose in acute coronary syndrome patients. High on-treatment platelet reactivity analysis of the TRIPLET trial. Diodati JG; Saucedo JF; Cardillo TE; Jakubowski JA; Henneges C; Effron MB; Lipkin FR; Walker JR; Duvvuru S; Sundseth SS; Fisher HN; Angiolillo DJ Thromb Haemost; 2014 Aug; 112(2):311-22. PubMed ID: 24718367 [TBL] [Abstract][Full Text] [Related]
11. Head to Head Comparison of Two Point-of-care Platelet Function Tests Used for Assessment of On-clopidogrel Platelet Reactivity in Chinese Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention. Yao Y; Zhang JH; Tang XF; He C; Ma YL; Xu JJ; Song Y; Liu R; Meng XM; Song L; Wang M; Gao RL; Yuan JQ Chin Med J (Engl); 2016 Oct; 129(19):2269-74. PubMed ID: 27647183 [TBL] [Abstract][Full Text] [Related]
12. A comparative cohort study on personalised antiplatelet therapy in PCI-treated patients with high on-clopidogrel platelet reactivity. Results of the ISAR-HPR registry. Mayer K; Schulz S; Bernlochner I; Morath T; Braun S; Hausleiter J; Massberg S; Schunkert H; Laugwitz KL; Kastrati A; Sibbing D Thromb Haemost; 2014 Aug; 112(2):342-51. PubMed ID: 24718389 [TBL] [Abstract][Full Text] [Related]
13. Association of PEAR1 genetic variants with platelet reactivity in response to dual antiplatelet therapy with aspirin and clopidogrel in the Chinese patient population after percutaneous coronary intervention. Yao Y; Tang XF; Zhang JH; He C; Ma YL; Xu JJ; Song Y; Liu R; Meng XM; Song L; Chen J; Wang M; Xu B; Gao RL; Yuan JQ Thromb Res; 2016 May; 141():28-34. PubMed ID: 26962983 [TBL] [Abstract][Full Text] [Related]
14. Association between platelet reactivity and circulating platelet-derived microvesicles in patients with acute coronary syndrome. Kafian S; Mobarrez F; Wallén H; Samad B Platelets; 2015; 26(5):467-73. PubMed ID: 25025694 [TBL] [Abstract][Full Text] [Related]
15. Body Mass Index and Platelet Reactivity During Dual Antiplatelet Therapy With Clopidogrel or Ticagrelor. Nardin M; Verdoia M; Sartori C; Pergolini P; Rolla R; Barbieri L; Schaffer A; Marino P; Bellomo G; Suryapranata H; De Luca G; J Cardiovasc Pharmacol; 2015 Oct; 66(4):364-70. PubMed ID: 26065844 [TBL] [Abstract][Full Text] [Related]
16. Predictors of high on-clopidogrel platelet reactivity in patients with acute coronary syndrome. Lee S; Hizoh I; Kovacs A; Horvath Z; Kiss N; Toth-Zsamboki E; Kiss RG Platelets; 2016; 27(2):159-67. PubMed ID: 26247099 [TBL] [Abstract][Full Text] [Related]
17. Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen). Park KW; Kang SH; Park JJ; Yang HM; Kang HJ; Koo BK; Park BE; Cha KS; Rhew JY; Jeon HK; Shin ES; Oh JH; Jeong MH; Kim S; Hwang KK; Yoon JH; Lee SY; Park TH; Moon KW; Kwon HM; Chae IH; Kim HS JACC Cardiovasc Interv; 2013 Sep; 6(9):932-42. PubMed ID: 24050860 [TBL] [Abstract][Full Text] [Related]
18. Optimizing P2Y12 receptor inhibition in patients with acute coronary syndrome on the basis of platelet function testing: impact of prasugrel and high-dose clopidogrel. Aradi D; Tornyos A; Pintér T; Vorobcsuk A; Kónyi A; Faluközy J; Veress G; Magyari B; Horváth IG; Komócsi A J Am Coll Cardiol; 2014 Mar; 63(11):1061-70. PubMed ID: 24486281 [TBL] [Abstract][Full Text] [Related]
19. [Effects of intensive antiplatelet therapy for patients with high on-treatment platelet reactivity after coronary stent implantation]. Guan SY; Han YL; Li Y; Guo L; Yang BS; Wang SL; Jing QM; Wang XZ; Ma YY; Liu XD Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Jan; 40(1):25-9. PubMed ID: 22490629 [TBL] [Abstract][Full Text] [Related]
20. Point-of-care assessment of platelet reactivity after clopidogrel to predict myonecrosis in patients undergoing percutaneous coronary intervention. Mangiacapra F; Barbato E; Patti G; Gatto L; Vizzi V; Ricottini E; D'Ambrosio A; Wijns W; Di Sciascio G JACC Cardiovasc Interv; 2010 Mar; 3(3):318-23. PubMed ID: 20298992 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]